Janus Henderson

Janus Henderson CEO Welcomes Peltz Deal, Excited for Private Ownership

Biohaven

Biohaven to Raise $125M from Janus Henderson Share Sale

JanusHenderson

Janus Henderson's 15min chart sees MACD Death Cross and KDJ Death Cross.

Janus Henderson Undervalues Shares in Deal with Trian Partners, General Catalyst: BofA

Janus Henderson's 15min chart indicates RSI overbought and KDJ death cross.

Catalyst<ul> <li>A MACD Death Cross occurred on January 9, which is interpreted as a bullish bias for JHG.</li></ul>Risk<ul> <li>Fund flows show negative outflows across all order sizes, indicating declining institutional confidence in JHG.</li> <li>Analyst ratings remain entirely neutral despite active coverage, suggesting limited consensus or strong conviction about JHG's prospects.</li></ul>

Key Factors

Halper Sadeh LLC announced an investigation into potential fiduciary duty breaches in pending deals involving Janus Henderson as of January 8, 2026.

Recent Updates

JHG News